BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37098542)

  • 1. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells.
    Tolue Ghasaban F; Maharati A; Akhlaghipour I; Moghbeli M
    Cancer Cell Int; 2023 Apr; 23(1):80. PubMed ID: 37098542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.
    Zangouei AS; Moghbeli M
    Genes Environ; 2021 Jun; 43(1):21. PubMed ID: 34099061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma.
    Moghbeli M
    Pathol Res Pract; 2023 Sep; 249():154743. PubMed ID: 37549518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells.
    Maharati A; Moghbeli M
    Eur J Pharmacol; 2023 Oct; 956():175937. PubMed ID: 37541368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers.
    Tolue Ghasaban F; Maharati A; Zangouei AS; Zangooie A; Moghbeli M
    Cancer Cell Int; 2023 Aug; 23(1):170. PubMed ID: 37587481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
    Abbasi A; Hosseinpourfeizi M; Safaralizadeh R
    Life Sci; 2022 Oct; 307():120884. PubMed ID: 35973456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway.
    Lin Q; Wang Y; Chen D; Sheng X; Liu J; Xiong H
    Oncol Lett; 2017 May; 13(5):3567-3571. PubMed ID: 28521459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
    Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J
    Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
    Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
    Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
    Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
    Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z; Si J; Nan J
    Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
    Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
    Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
    Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
    Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.
    Moghbeli M
    J Ovarian Res; 2021 Sep; 14(1):127. PubMed ID: 34593006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
    Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
    Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.